{"id":"https://openalex.org/W4388084818","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","title":"1509-A Dual IFN\u03b3 and TNF\u03b1 signaling controls homing receptor ligand expression in tumor-associated endothelial cells","display_name":"1509-A Dual IFN\u03b3 and TNF\u03b1 signaling controls homing receptor ligand expression in tumor-associated endothelial cells","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388084818","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1509-a","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_2/A1854.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts \u2013 Part 2","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_2/A1854.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089427330","display_name":"Mirna Perusina Lanfranca","orcid":"https://orcid.org/0000-0002-3845-2585","observed_orcids":["https://orcid.org/0000-0002-3845-2585"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mirna Perusina Lanfranca","raw_affiliation_strings":["University of Virginia, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017402491","display_name":"Robin S. Lindsay","orcid":"https://orcid.org/0000-0001-7867-8653","observed_orcids":["https://orcid.org/0000-0001-7867-8653"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robin Lindsay","raw_affiliation_strings":["University of Virginia, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048037456","display_name":"Katarzyna Stasiak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katarzyna Stasiak","raw_affiliation_strings":["University of Virginia, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084586982","display_name":"Andrew C. Dudley","orcid":"https://orcid.org/0000-0002-2663-1949","observed_orcids":["https://orcid.org/0000-0002-2663-1949"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew C Dudley","raw_affiliation_strings":["University of Virginia, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029720935","display_name":"V\u00edctor H. Engelhard","orcid":"https://orcid.org/0000-0002-1741-0925","observed_orcids":["https://orcid.org/0000-0002-1741-0925"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Victor Engelhard","raw_affiliation_strings":["University of Virginia, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I51556381"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1854","last_page":"A1854"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.8974999785423279,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.04439999908208847,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.04399999976158142,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-associated-endothelial-cells","display_name":"tumor endothelial cells","score":0.9459999799728394},{"id":"https://openalex.org/keywords/interferon-gamma-signaling","display_name":"interferon-gamma signaling","score":0.9440000057220459},{"id":"https://openalex.org/keywords/tnf-signaling","display_name":"TNF signaling","score":1.0},{"id":"https://openalex.org/keywords/vcam-1","display_name":"VCAM-1","score":0.9399999976158142},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":1.0},{"id":"https://openalex.org/keywords/cxcl9","display_name":"CXCL9","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":1.0},{"id":"https://openalex.org/keywords/vascular-endothelial-growth-factor","display_name":"vascular endothelial growth factor","score":0.9409999847412109},{"id":"https://openalex.org/keywords/fgf2","display_name":"FGF2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.47999998927116394},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.41200000047683716},{"id":"https://openalex.org/keywords/endothelial-cell-gene-expression","display_name":"endothelial cell gene expression","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.601832389831543},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.5796051025390625},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.5306153893470764},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5171886682510376},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.5103999972343445},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.5018484592437744},{"id":"https://openalex.org/C5858377","wikidata":"https://www.wikidata.org/wiki/Q986112","display_name":"CXCL10","level":4,"score":0.4747360646724701},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.46446651220321655},{"id":"https://openalex.org/C151872237","wikidata":"https://www.wikidata.org/wiki/Q1410759","display_name":"Homing (biology)","level":2,"score":0.46077650785446167},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4490245580673218},{"id":"https://openalex.org/C84913492","wikidata":"https://www.wikidata.org/wiki/Q5014892","display_name":"CXC chemokine receptors","level":5,"score":0.4482212960720062},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4337247610092163},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4278208613395691},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.42767333984375},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.41417670249938965},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.32803672552108765},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1509-a","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_2/A1854.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts \u2013 Part 2","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:76e804be85614824a9d6fb0bf1f2626a","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/76e804be85614824a9d6fb0bf1f2626a","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1509-a","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1509-a","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_2/A1854.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular Abstracts \u2013 Part 2","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388084818.pdf","grobid_xml":"https://content.openalex.org/works/W4388084818.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4388080535","https://openalex.org/W2175249241","https://openalex.org/W1969880562","https://openalex.org/W2169403180","https://openalex.org/W2028790854","https://openalex.org/W2765929905","https://openalex.org/W2051379819","https://openalex.org/W2007385259","https://openalex.org/W1518633297","https://openalex.org/W2765403010"],"abstract_inverted_index":{"Background":[0],"Tumor":[1],"endothelial":[2,119],"cells":[3,25,69,120],"(TECs)":[4],"play":[5,18],"a":[6,19,342],"crucial":[7],"role":[8,20,111],"in":[9,21,70,89,118,150,158,160,193,204,210,295,299,307,321,336],"the":[10,22,30,39,44,50,60,90,96,109,132,145,246,286,316,339],"development":[11],"and":[12,28,56,59,80,116,124,128,136,144,148,153,162,172,186,188,214,235,253,276,328],"progression":[13],"of":[14,46,52,62,66,112,141,220,241,249,266,268,288,291,309,318,345,354],"cancer.":[15],"TECs":[16,34,233,308],"also":[17,301],"way":[23],"cancer":[24,47,72,355],"interact":[26],"with":[27,35,76,176,239],"evade":[29],"immune":[31],"system.":[32],"Targeting":[33],"specific":[36,154,292],"therapies":[37],"has":[38],"potential":[40],"to":[41,351],"greatly":[42],"impact":[43,287],"treatment":[45,278],"by":[48,131,325],"stopping":[49],"growth":[51],"new":[53],"blood":[54],"vessels":[55],"improving":[57],"infiltration":[58],"effectiveness":[61,353],"immunotherapies.":[63,356],"The":[64],"presence":[65],"CD8":[67],"T":[68],"several":[71],"types":[73],"is":[74],"associated":[75],"better":[77,343],"clinical":[78],"outcomes":[79],"while":[81,271],"we":[82,138,179,201,243],"know":[83],"that":[84,98,181,203,245,329],"homing":[85],"receptor":[86,216],"ligands":[87],"(HRL)":[88],"vasculature":[91],"regulate":[92],"entry":[93],"into":[94],"tumors,":[95],"factors":[97,134,294],"control":[99],"their":[100],"local":[101],"expression":[102,140,219,248,265,290,306,320],"are":[103,333],"incompletely":[104],"characterized.":[105],"Methods":[106],"To":[107],"distinguish":[108],"regulatory":[110],"pro-inflammatory":[113],"cytokines":[114],"(IFN\u03b3":[115],"TNF\u03b1)":[117],"from":[121,206],"tumor":[122],"(TEC)":[123],"normal":[125],"tissues":[126],"(EC)":[127],"its":[129],"antagonism":[130],"angiogenic":[133],"VEGF":[135,258],"FGF2,":[137],"evaluated":[139],"VCAM-1,":[142],"ICAM-1,":[143],"chemokines":[146],"CXCL9":[147,192],"CXCL10":[149],"cell":[151],"lines":[152],"knock":[155],"out":[156],"mice":[157],"vitro,":[159],"vivo,":[161],"ex":[163,237],"vivo":[164,238,300],"using":[165],"mainly":[166],"flow":[167],"cytometry,":[168],"immunofluorescence,":[169],"western":[170],"blot,":[171],"qPCR":[173],"Results":[174],"Consistent":[175],"other":[177],"studies,":[178],"found":[180,202,244],"TNF\u03b1":[182,215,254],"alone":[183,190],"upregulated":[184,191],"VCAM-1":[185],"ICAM-I,":[187],"IFN\u03b3":[189,212,252],"3":[194],"long-term":[195],"murine":[196],"EC":[197,326],"lines.":[198],"In":[199,232,338],"contrast,":[200],"TEC":[205,322],"B16F1OVA":[207],"tumors":[208],"implanted":[209],"either":[211,263],"KO":[213,217],"mice,":[218],"these":[221,269,346],"HRL":[222,250,270,305,319],"was":[223,273],"substantially":[224],"decreased,":[225],"demonstrating":[226],"co-dependence":[227],"on":[228,262],"both":[229],"signaling":[230],"pathways.":[231],"isolated":[234],"cultured":[236],"combination":[240],"cytokines,":[242],"sustained":[247],"required":[251],"dual":[255,277],"treatment.":[256],"Surprisingly,":[257],"had":[259],"little":[260],"effect":[261],"cytokine-driven":[264],"any":[267],"FGF2":[272],"strongly":[274],"inhibitory,":[275],"partially":[279],"reversed":[280],"this":[281],"restriction.":[282],"Additionally,":[283],"it":[284],"compensated":[285],"decreased":[289],"transcription":[293],"TECs.":[296],"Furthermore,":[297],"trends":[298],"imply":[302],"an":[303],"improved":[304,352],"dual-treated":[310],"tumors.":[311,337],"Conclusions":[312],"These":[313],"results":[314],"demonstrate":[315],"complexity":[317],"(inadequately":[323],"recapitulated":[324],"lines)":[327],"some":[330],"individual":[331],"pathways":[332],"actively":[334],"suppressed":[335],"long":[340],"term,":[341],"understanding":[344],"mechanisms":[347],"will":[348],"directly":[349],"lead":[350]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}